RecruitingPhase 2NCT05873192
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Houston, TX
Phase 2 Prostate Cancer clinical trials
80 recruiting Phase 2 prostate cancer studies in the US. What trial phases mean
Other phases
RecruitingPhase 2NCT06096870
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Sponsor: National Cancer Institute (NCI)
Bethesda, MD
RecruitingPhase 2NCT06161506
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Bethesda, MD
RecruitingPhase 2NCT05691465
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Sponsor: National Cancer Institute (NCI)
Duarte, CA · Los Angeles, CA · +10 more sites
RecruitingPhase 2NCT06049355
EMBRACE: Exercising Together
Sponsor: OHSU Knight Cancer Institute
Portland, OR
RecruitingPhase 2NCT07287150
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Hoffmann-La Roche
Los Angeles, CA · San Francisco, CA · Iowa City, IA · +3 more sites
RecruitingPhase 2NCT07745361
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Sponsor: Monte Rosa Therapeutics, Inc
Los Angeles, CA · Newport Beach, CA · Colorado Springs, CO · +11 more sites
RecruitingPhase 2NCT06738303
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Sponsor: Case Comprehensive Cancer Center
Cleveland, OH
RecruitingPhase 2NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Sponsor: Daiichi Sankyo
Duarte, CA · New Haven, CT · Kissimmee, FL · +10 more sites
RecruitingPhase 2NCT07285044
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Sponsor: Mayo Clinic
Jacksonville, FL
RecruitingPhase 2NCT07185165
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Sponsor: Jonsson Comprehensive Cancer Center
Los Angeles, CA
RecruitingPhase 2NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Sponsor: AstraZeneca
Los Angeles, CA · San Diego, CA · Santa Rosa, CA · +15 more sites
RecruitingPhase 2NCT07025369
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Sponsor: Mayo Clinic
Scottsdale, AZ
RecruitingPhase 2NCT07550517
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, MD
RecruitingPhase 2NCT07234981
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Sponsor: University of Nebraska
Omaha, NE
RecruitingPhase 2NCT04038502
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Sponsor: VA Office of Research and Development
West Los Angeles, CA · Aurora, CO · Washington D.C., DC · +15 more sites
RecruitingPhase 2NCT05011383
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Sponsor: VA Office of Research and Development
Aurora, CO · West Haven, CT · Gainesville, FL · +14 more sites
RecruitingPhase 2NCT07332000
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Sponsor: Candel Therapeutics, Inc.
Peoria, AZ · Lakewood, CO · Littleton, CO · +4 more sites
RecruitingPhase 2NCT06111781
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Sponsor: Yale University
New Haven, CT · Lebanon, NH · New York, NY · +1 more sites
RecruitingPhase 2NCT05766371
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Sponsor: University of California, San Francisco
San Francisco, CA
RecruitingPhase 2NCT07224009
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
Sponsor: University of Arkansas
Little Rock, AR
RecruitingPhase 2NCT05726292
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Sponsor: University of Chicago
Chicago, IL · Evanston, IL · Portland, OR · +1 more sites
RecruitingPhase 2NCT07111507
A Study of Tarlatamab for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
San Diego, CA · San Francisco, CA · Basking Ridge, NJ · +7 more sites
RecruitingPhase 2NCT07218666
Zanzalintinib in Men With Aggressive Variant Prostate Cancer
Sponsor: Deepak Kilari
Milwaukee, WI
RecruitingPhase 2NCT06022822
Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial
Sponsor: National Cancer Institute (NCI)
Los Angeles, CA · Chicago, IL · +2 more sites
RecruitingPhase 2NCT06844383
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Sponsor: Prostate Cancer Clinical Trials Consortium
Duarte, CA · La Jolla, CA · Boston, MA · +5 more sites
RecruitingPhase 2NCT07237269
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Sponsor: University of Nebraska
Omaha, NE
RecruitingPhase 2NCT06842498
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sponsor: Kyntra Bio
Goodyear, AZ · Scottsdale, AZ · Tucson, AZ · +20 more sites
RecruitingPhase 2NCT07202247
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
Sponsor: City of Hope Medical Center
Duarte, CA
RecruitingPhase 2NCT07751159
Radiation Therapy Approaches for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Basking Ridge, NJ · Middletown, NJ · Montvale, NJ · +4 more sites
RecruitingPhase 2NCT05832086
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Sponsor: Stephen Freedland
Duarte, CA · Los Angeles, CA · Durham, NC
RecruitingPhase 2NCT06145633
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Sponsor: Fred Hutchinson Cancer Center
Seattle, WA
RecruitingPhase 2NCT07455903
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Sponsor: Baptist Health South Florida
Miami, FL
RecruitingPhase 2NCT07364071
Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
Sponsor: University of California, San Diego
La Jolla, CA
RecruitingPhase 2NCT05751434
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Sponsor: City of Hope Medical Center
Durate, CA · Los Angeles, CA · Hartford, CT · +7 more sites
RecruitingPhase 2NCT05765500
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Sponsor: Dana-Farber Cancer Institute
Boston, MA · Foxborough, MA
RecruitingPhase 2NCT06378866
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Sponsor: Mayo Clinic
Phoenix, AZ · Jacksonville, FL · Rochester, MN
RecruitingPhase 2NCT06865768
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Sponsor: Emory University
Atlanta, GA
RecruitingPhase 2NCT06568562
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: University of Utah
Salt Lake City, UT
RecruitingPhase 2NCT04947254
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Houston, TX
RecruitingPhase 2NCT07216248
Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer
Sponsor: University of Utah
Salt Lake City, UT
RecruitingPhase 2NCT07635238
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Basking Ridge, NJ · Middletown, NJ · Montvale, NJ · +4 more sites
RecruitingPhase 2NCT05790213
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
Sponsor: University of Chicago
Chicago, IL
RecruitingPhase 2NCT06392295
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
Sponsor: University of Miami
Miami, FL
RecruitingPhase 2NCT05422911
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Sponsor: Sun Pharmaceutical Industries Limited
Los Angeles, CA · Tampa, FL · Ann Arbor, MI · +9 more sites
RecruitingPhase 2NCT06675357
Using FAPI PET/MRI to Evaluate Prostate Cancer
Sponsor: University of Wisconsin, Madison
Madison, WI
RecruitingPhase 2NCT03821246
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Sponsor: David Oh
San Francisco, CA · St Louis, MO
RecruitingPhase 2NCT07476001
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL
RecruitingPhase 2NCT04606446
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Sponsor: Pfizer
Scottsdale, AZ · Los Angeles, CA · +20 more sites
RecruitingPhase 2NCT07073794
Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
Sponsor: Mayo Clinic
Jacksonville, FL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.